<DOC>
	<DOCNO>NCT01714843</DOCNO>
	<brief_summary>This study investigate efficacy , safety , plasma concentration change ASP0456 patient constipation-predominant irritable bowel syndrome .</brief_summary>
	<brief_title>A Study Evaluate Effect ASP0456 Patients With Constipation Predominant Irritable Bowel Syndrome</brief_title>
	<detailed_description>This study multicenter , double-blind , placebo-controlled , parallel-group , comparative study investigate dose-responses efficacy , safety , pharmacokinetics ASP0456 patient constipation-predominant irritable bowel syndrome ( IBS-C ) accord Rome III Diagnostic Criteria ( 2006 revise edition , establish Rome III Committee ) oral administration ASP0456 .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Patients abdominal pain discomfort repeatedly least 3 day per month 3 month screen examination associate least 2 follow 3 condition : ( 1 ) Improvement defecation ; ( 2 ) Onset associate change frequency stool ; ( 3 ) Onset associate change form ( appearance ) stool , symptom ( IBS symptom ) 6 month screen examination period . Patients â‰¥25 % stool hard lumpy ( bowel movement occur without antidiarrheal , laxative , suppository enema ) &lt; 25 % loose ( mushy ) watery 3 month screen examination . Patients pancolonoscopy contrast enema ( sigmoidoscopy ) onset IBS symptom organic change . Patients history surgical resection stomach , gallbladder , small intestine large intestine Patients concurrent disease may affect digestive tract passage large intestinal function Patients concurrent disease may affect assessment abdominal pain/discomfort Patients blood pressure , pulse rate , clinical laboratory test , 12lead ECG time screen examination rat Grade 2 great `` Severity Criteria Drug Adverse Reaction '' judge clinically significant</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>ASP0456</keyword>
	<keyword>constipation</keyword>
	<keyword>irritable bowel syndrome ( IBS )</keyword>
	<keyword>linaclotide</keyword>
</DOC>